Cite

HARVARD Citation

    Leonard, B. et al. (2019). ATR inhibition sensitizes HPV− and HPV+ head and neck squamous cell carcinoma to cisplatin. Oral oncology. pp. 35-42. [Online]. 
  
Back to record